Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Algernon Pharmaceuticals Inc (CN: AGN)

 
AGN Technical Analysis
5
As on 14th Nov 2024 AGN STOCK Price closed @ 0.08 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.13 & Strong Sell for SHORT-TERM with Stoploss of 0.21 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AGNSTOCK Price

Open 0.08 Change Price %
High 0.08 1 Day 0.00 0.00
Low 0.08 1 Week 0.00 0.00
Close 0.08 1 Month -0.01 -11.11
Volume 21000 1 Year -0.14 -63.64
52 Week High 0.24 | 52 Week Low 0.06
 
CN Canada Most Active Stocks
BTC 0.70 169.23%
BIGG 0.22 15.79%
FNQ 0.01 %
ACDC 0.06 0.00%
RVV 0.01 %
FMAN 0.55 7.84%
TER 2.80 5.66%
GSK 0.54 20.00%
IP 0.12 -14.29%
USGD 0.16 14.29%
 
CN Canada Top Gainers Stocks
BTC 0.70 169.23%
BTC 0.70 169.23%
BTC 0.70 169.23%
BLR 0.02 100.00%
BLR 0.02 100.00%
BLR 0.02 100.00%
XCX 0.02 100.00%
MICH 0.13 62.50%
LLL 0.14 55.56%
LLL 0.14 55.56%
 
CN Canada Top Losers Stocks
GTG 0.37 -97.30%
GTG 0.37 -97.30%
MJRX 0.01 -50.00%
XBLK 0.02 -50.00%
SLZ 0.02 -50.00%
SLZ 0.02 -50.00%
SLZ 0.02 -50.00%
BAMM 0.02 -33.33%
CNTR 0.02 -33.33%
GOH 0.06 -33.33%
 
 
AGN
Daily Charts		 AGN
Intraday Charts		 Whats New @
Bazaartrend		 AGN
Free Analysis
 
AGN Important Levels Intraday
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
RESISTANCE0.08
 
AGN Forecast November 2024
Share
4th UP Forecast0.23
3rd UP Forecast0.18
2nd UP Forecast0.15
1st UP Forecast0.12
1st DOWN Forecast0.04
2nd DOWN Forecast0.01
3rd DOWN Forecast-0.02
4th DOWN Forecast-0.07
 
AGN Weekly Forecast
4th UP Forecast0.20
3rd UP Forecast0.16
2nd UP Forecast0.14
1st UP Forecast0.11
1st DOWN Forecast0.05
2nd DOWN Forecast0.02
3rd DOWN Forecast0.00
4th DOWN Forecast-0.04
 
AGN Forecast2024
4th UP Forecast0.47
3rd UP Forecast0.34
2nd UP Forecast0.27
1st UP Forecast0.19
1st DOWN Forecast-0.03
2nd DOWN Forecast-0.11
3rd DOWN Forecast-0.18
4th DOWN Forecast-0.31
 
 
AGN Other Details
Segment EQ
Market Capital 12561526.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
AGN Address
AGN
 
AGN Latest News
 
Your Comments and Response on Algernon Pharmaceuticals Inc
 
AGN Business Profile
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non?alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets NMDA-type subunit 2B (Glu2NB), as well as exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. It is also developing AP-188 (N,N-Dimethyltryptamine), a psychedelic compound that is part of the tryptamine family for the treatment of ischemic stroke in humans. Algernon Pharmaceuticals Inc. has an agreement with Charles River Laboratories for preclinical studies of AP-188 for the company's stroke clinical research program. Algernon Pharmaceuticals Inc. is headquartered in Vancouver, Canada. Address: 700 West Pender Street, Vancouver, BC, Canada, V6C 1G8
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service